Vice Dean of Clinical Affairs, Professor of Surgery
1281 Scott Hall
540 E. Canfield
Charles Shanley, M.D., F.A.C.S., professor of Surgery, is vice dean for Clinical Affairs for the Wayne State University School of Medicine. He also serve as president and chief executive officer of the Wayne State University Physician Group.
A Detroit native, Dr. Shanley has served in a variety of clinical and academic management roles throughout the course of his leadership career, including residency program director for both general surgery and vascular surgery, division chief for vascular surgery and surgical department chair. He also served in a number of health system operational and management roles, as senior vice president for Surgical Services and co-medical director for William Beaumont Hospital, Royal Oak from 2006 to 2009, where he was the lead physician executive for one of the largest surgical enterprises by volume in the nation. Surgical services operations at Beaumont included more than 900 full-time staff as well as 460 attending and associate surgeons with an annual operating budget of $150 million.
In 2009, Dr. Shanley was appointed senior vice president for Professional (Physician) Services and associate chief medical officer for Beaumont Health, and was primarily accountable for the restructuring of the physician compensation and incentive plan. In 2010, he co-founded Medical Engineering Partners LLC, an advanced bioengineering and medical device prototyping firm with fellow WSU faculty member Gregory Auner, Ph.D. They successfully completed Series A financing in 2017 for Detroit-based Seraph Biosciences Inc. (founded in 2014), to commercialize a novel Raman-spectroscopic diagnostic platform that is based in part upon intellectual property licensed from WSU for real-time pathogen and agent detection at the point of care.
A distinguished fellow of the Society for Vascular Surgery, Dr. Shanley’s research has been funded by the Department of Defense Telemedicine and Advanced Technology Research Center, the Michigan Economic Development Corp. and the National Institutes of Health. He serves on the Health Care Patient Safety and Quality Study Section of the Agency for Health Care Research and Quality, and was appointed to the Circulatory Devices Advisory Panel of the U.S. Food and Drug Administration.